X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
optimize-hf (135) 135
humans (130) 130
index medicus (128) 128
cardiac & cardiovascular systems (120) 120
heart failure (111) 111
male (101) 101
female (100) 100
mortality (91) 91
aged (89) 89
initiate lifesaving treatment (67) 67
organized program (62) 62
heart failure - mortality (60) 60
aged, 80 and over (58) 58
outcomes (58) 58
heart failure - therapy (56) 56
middle aged (56) 56
hospitalization (52) 52
prognosis (48) 48
cardiovascular (45) 45
abridged index medicus (42) 42
hospitalized-patients (39) 39
registries (36) 36
association (34) 34
cardiac patients (34) 34
treatment outcome (34) 34
acute disease (33) 33
heart failure - diagnosis (33) 33
heart failure - physiopathology (33) 33
risk factors (31) 31
prospective studies (28) 28
united states (27) 27
article (25) 25
heart failure - drug therapy (25) 25
registry (25) 25
acute heart failure (24) 24
follow-up studies (24) 24
heart failure - epidemiology (23) 23
management (22) 22
time factors (22) 22
quality-of-care (21) 21
hospital mortality (20) 20
patient outcomes (20) 20
retrospective studies (20) 20
hospitals (19) 19
in-hospital mortality (19) 19
stroke volume (19) 19
medicare (18) 18
united states - epidemiology (18) 18
medicine, general & internal (17) 17
care and treatment (16) 16
comorbidity (16) 16
disease (16) 16
optimize-hf registry (16) 16
predictors (16) 16
risk assessment (16) 16
clinical-outcomes (15) 15
guidelines (15) 15
heart failure - blood (15) 15
clinical characteristics (14) 14
heart failure - complications (14) 14
hospitalization - statistics & numerical data (14) 14
patients (14) 14
risk (14) 14
survival (14) 14
trial (14) 14
analysis (13) 13
care (13) 13
cohort studies (13) 13
proportional hazards models (13) 13
readmission (13) 13
national registry adhere (12) 12
patient readmission - statistics & numerical data (12) 12
risk stratification (12) 12
acute myocardial-infarction (11) 11
drug therapy (11) 11
heart attacks (11) 11
medicare beneficiaries (11) 11
morbidity (11) 11
program (11) 11
stroke volume - physiology (11) 11
worsening renal-function (11) 11
cardiology and cardiovascular medicine (10) 10
clinical trials (10) 10
confidence intervals (10) 10
ejection fraction (10) 10
heart (10) 10
natriuretic peptide (10) 10
natriuretic peptide, brain - blood (10) 10
patient readmission (10) 10
predictive value of tests (10) 10
preserved ejection fraction (10) 10
prevalence (10) 10
severity of illness index (10) 10
survival analysis (10) 10
adrenergic beta-antagonists - therapeutic use (9) 9
adult (9) 9
angiotensin-converting enzyme inhibitors - therapeutic use (9) 9
brain natriuretic peptide (9) 9
cardiology (9) 9
diagnosis (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 07/2017, Volume 70, Issue 3, pp. 332 - 341
BACKGROUND Advanced heart failure (HF) is characterized by high morbidity and mortality. Conventional therapy may not sufficiently reduce patient suffering and... 
heart failure | HOSPITALIZED-PATIENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | FUNCTIONAL ASSESSMENT | ORGANIZED PROGRAM | INITIATE LIFESAVING TREATMENT | palliative care | DISCHARGE | OPTIMIZE-HF | QUALITY-OF-LIFE | OUTCOMES | SCALE | quality of life | HEALTH-STATUS
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 06/2015, Volume 175, Issue 6, pp. 996 - 1004
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2014, Volume 63, Issue 12, pp. 1123 - 1133
Heart failure is a global pandemic affecting an estimated 26 million people worldwide and resulting in more than 1 million hospitalizations annually in both... 
acute | heart failure | registry | hospitalization | inpatient | VENTRICULAR EJECTION FRACTION | CARDIAC & CARDIOVASCULAR SYSTEMS | QUALITY-OF-CARE | OPTIMIZE-HF REGISTRY | ORGANIZED PROGRAM | EUROBSERVATIONAL RESEARCH-PROGRAM | STROKE STATISTICS-2012 UPDATE | INITIATE LIFESAVING TREATMENT | ONE-YEAR MORTALITY | PHYSICIAN FOLLOW-UP | PRESERVED SYSTOLIC FUNCTION | Age Distribution | Vasodilator Agents - therapeutic use | Anemia - epidemiology | United States | Humans | Catheterization, Swan-Ganz - utilization | Male | Dyspnea - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Electrocardiography | Female | Registries | Coronary Angiography - utilization | Heart Failure - diagnosis | Heart Failure - epidemiology | Heart Failure - etiology | Drug Utilization - statistics & numerical data | Length of Stay - statistics & numerical data | Adrenergic beta-Antagonists - therapeutic use | Hyponatremia - epidemiology | Cardiac Resynchronization Therapy - utilization | Echocardiography | Glomerular Filtration Rate | Hospital Mortality | Comorbidity | Europe | Defibrillators, Implantable - utilization | Hospitalization | Evidence-Based Medicine | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Quality Improvement | Asia | Natriuretic Peptides - analysis | Sex Distribution | Diuretics - therapeutic use | Aged | Angiotensin Receptor Antagonists - therapeutic use | Heart failure | Medical colleges | Medical research | Mortality | Therapeutics | Economic aspects | Medicine, Experimental | Natriuretic peptides | Homeopathy | Materia medica and therapeutics
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2013, Volume 61, Issue 4, pp. 391 - 403
With a prevalence of 5.8 million in the United States alone, heart failure (HF) is associated with high morbidity, mortality, and healthcare expenditures.... 
heart failure | outcomes | readmission | VENTRICULAR EJECTION FRACTION | CARDIAC & CARDIOVASCULAR SYSTEMS | OPTIMIZE-HF REGISTRY | INITIATE LIFESAVING TREATMENT | FOLLOW-UP | VASOPRESSIN ANTAGONISM | READMISSION RATES | BETA-BLOCKER THERAPY | EVEREST TRIAL | MEDICARE BENEFICIARIES | CLINICAL-OUTCOMES | United States - epidemiology | Prognosis | Humans | Middle Aged | Heart Failure - physiopathology | Cost of Illness | Male | Evidence-Based Practice - methods | Heart Failure - therapy | Patient Discharge - statistics & numerical data | Aged, 80 and over | Female | Heart Failure - diagnosis | Heart Failure - economics | Heart Failure - epidemiology | Length of Stay - statistics & numerical data | Severity of Illness Index | Risk Assessment | Comorbidity | Patient Readmission - economics | Survival Rate | Stroke Volume | Outcome and Process Assessment (Health Care) | Patient Discharge - standards | Aged | Disease Management | Patient Readmission - statistics & numerical data | Health care | Heart failure | Heart | Medical research | Heart attacks | Medicare | Mortality | Abnormalities | Clinical trials | Cardiovascular disease | Hospitalization | Disease control | Patients | Discharge | Morbidity | Hospitals | Electrocardiography | Expenditures | Chronic obstructive pulmonary disease | Drug therapy | Heart diseases | Ejection
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2013, Volume 61, Issue 2, pp. 121 - 126
Journal Article
Journal Article
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 01/2019, Volume 132, Issue 1, pp. 71 - 80.e1
The efficacy of mineralocorticoid receptor antagonists or aldosterone antagonists in heart failure with reduced ejection fraction (HFrEF) is well known. Less... 
Heart failure | Readmission | Spironolactone | Mortality | Ejection fraction | MILD PATIENTS HOSPITALIZATION | PROPENSITY SCORE | HYPERKALEMIA | ALDOSTERONE ANTAGONIST THERAPY | RENIN-ANGIOTENSIN INHIBITION | MEDICINE, GENERAL & INTERNAL | OPTIMIZE-HF | MEDICARE BENEFICIARIES | ALL-CAUSE READMISSION | CHRONIC KIDNEY-DISEASE | WORSENING RENAL-FUNCTION
Journal Article